| 1-R13-EB036360-01 |
2024 World Molecular Imaging Congress (WMIC) |
Henry Manning |
World Molecular Imaging Society |
| 5-R01-EB032264-04 |
Accelerating the discovery and development of neurotracers via high-throughput radiochemistry |
Robert Van Dam |
University of California Los Angeles |
| 1-R21-EB034882-01A1 |
Antibiotic-based PET Imaging of Implant Associated Gram-positive Bacterial Infections |
Daniel Thorek |
Washington University |
| 5-R01-EB031008-04 |
Artificial Intelligence Boosted Evolution and Detection of Genetically Encoded Reporters for In Vivo Imaging |
Christian Farrar |
Massachusetts General Hospital |
| 5-R01-EB027172-06 |
Biocompatible fluorophores for shortwave infrared imaging |
Ellen Sletten |
University of California Los Angeles |
| 1-R15-EB031528-01 |
Biocompatible Graphene Quantum Dots for Noninvasive Near-infrared Bioimaging |
Anton Naumov |
Texas Christian University |
| 5-T32-EB027629-05 |
Caltech/UCLA Individualized Theranostic Engineering to Advance Metabolic System (iTEAM) |
Tzung Hsiai |
University of California Los Angeles |
| 5-R21-EB032495-02 |
Catch and Release Radiolabeled Peptides: a new technology for radiotracer development |
Matthew Parker |
State University New York Stony Brook |
| 1-R01-EB036942-01 |
Cerium oxide nanoparticles for CT imaging and catalytic therapeutic intervention in inflammatory bowel disease |
David Cormode |
University of Pennsylvania |
| 7-R56-EB029259-06 |
Chelators to Enable Theranostic Alpha Particle Radiotherapeutic Agents |
Justin Wilson |
University of California Santa Barbara |
